1.本数据库收录EMA集中程序以及经HMA协调通过互认可程序或分权程序获得批准上市的药品
2.查询欧盟成员国上市的相关信息,点击欧盟成员国上市
掌握医院、零售、 电商 三大终端市场的销售脉搏,就用 药品市场全终端分析系统 (←点击链接免费试用)
全面洞察药品零售数据,助力企业精准决策,把握市场增长,就用穿云众客-零售药品消费分析决策系统(←点击链接免费试用)
商标名 | 通用名称 | 中文名称 | ATC编码 | 授权日期 | 上市许可持有人 | 市场状态 |
---|---|---|---|---|---|---|
Rilonacept FGK Representative Service GmbH | rilonacept | 利纳西普 | L04AC04 | Rilonacept FGK Representative Service GmbH | Application withdrawn | |
Trabectedin Accord | trabectedin | 曲贝替定 | L01CX01 | Accord Healthcare S.L.U. | Opinion | |
Pelgraz Paediatric | pegfilgrastim | 培非司亭 | L03AA13 | Accord Healthcare S.L.U. | Application withdrawn | |
Lynozyfic | linvoseltamab | 林沃妥单抗 | L01FX | Regeneron Ireland Designated Activity Company (DAC) | Opinion | |
Nexviadyme | Avalglucosidase alfa | 艾夫糖苷酶α | A16 | 2022-06-24 | Sanofi B.V. | Authorised |
Cabometyx | cabozantinib | L01EX07 | 2016-09-09 | Ipsen Pharma | Authorised | |
Cometriq | cabozantinib | 苹果酸卡博替尼 | L01XE | 2014-03-21 | Ipsen Pharma | Authorised |
Bimervax | COVID-19 Vaccine (recombinant, adjuvanted);selvacovatein;damlecovatein | J07BN | 2023-03-30 | Hipra Human Health S.L. | Authorised | |
Upstaza | eladocagene exuparvovec | 艾依卡基 | A16AB26 | 2022-07-18 | PTC Therapeutics International Limited | Authorised |
Vitrakvi | larotrectinib | 硫酸拉罗替尼 | L01XE53 | 2019-09-19 | Bayer AG | Authorised |
Elonva | corifollitropin alfa | 绒促卵泡素α | G03GA09 | 2010-01-25 | N.V. Organon | Authorised |
Caelyx pegylated liposomal | doxorubicin | 盐酸多柔比星 | L01DB | 1996-06-20 | Baxter Holding B.V. | Authorised |
RotaTeq | rotavirus vaccine, live | 轮状病毒减毒活疫苗 | J07BH02 | 2006-06-26 | Merck Sharp & Dohme B.V. | Authorised |
Dapagliflozin Viatris | dapagliflozin | 达格列净 | A10BK01 | 2023-03-24 | Viatris Limited | Authorised |
Orgalutran | ganirelix | 醋酸加尼瑞克 | H01CC01 | 2000-05-16 | N.V. Organon | Authorised |
Briviact (in Italy: Nubriveo) | brivaracetam | 布瓦西坦 | N03AX23 | 2016-01-13 | UCB Pharma SA | Authorised |
RoActemra | tocilizumab | 托珠单抗 | L04AC07 | 2009-01-16 | Roche Registration GmbH | Authorised |
Fuzeon | enfuvirtide | 恩夫韦肽 | J05AX07 | 2003-05-27 | Roche Registration GmbH | Authorised |
COVID-19 Vaccine (inactivated, adjuvanted) Valneva | COVID-19 vaccine (inactivated, adjuvanted, adsorbed) | J07BX03 | 2022-06-24 | Valneva Austria GmbH | Withdrawn | |
Thyrogen | thyrotropin alfa | 促甲状腺素α | H01AB01 | 2000-03-09 | Sanofi B.V. | Authorised |